PATENT CLAIM ANALYSIS

Application Number: 15743764
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "136100"]

Abstract:
The present disclosure relates to antibody molecules comprising a binding domain specific to CD79, said binding domain comprising SEQ ID NO: 1, 2, 3 or 4, and/or SEQ ID NO: 5, 6 and 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.

Claim (Index 12):
The antibody molecule according to any one of  claim 1 ,  3 - 5 , or  7 - 11  wherein VH and VL are humanised.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.55
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15743756', '15326501', '15311198', '14960015', '15087405']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8062074669368968
- 35 USC 102 Novelty (BERT): 0.6395291580693778
- Combined Prediction Score: 0.7895396360501449
- Mean Citation Score: 484.271568
- Max Citation Score: 683.33405
- Similarity Product: 550.8675988224151

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test